KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 118 filers reported holding KURA ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $5,452,000 | -21.5% | 311,536 | -18.3% | 1.04% | -2.8% |
Q2 2018 | $6,943,000 | +5.2% | 381,459 | +8.4% | 1.08% | -1.1% |
Q1 2018 | $6,599,000 | -3.2% | 351,955 | -21.0% | 1.09% | -13.5% |
Q4 2017 | $6,817,000 | +76.4% | 445,550 | +72.3% | 1.26% | +26.5% |
Q3 2017 | $3,865,000 | – | 258,516 | – | 0.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |